Universal Access and Affordable Medicines
Our campaign promotes transparency, accountability and the public interest in the field of pharmaceuticals. Our evidence-based advocacy aims to guarantee better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and calling for better access to medicines for all.
About our work on access to medicines
Ensure equitable global access for treatments, vaccines and diagnostics resulting from the ACT Accelerator, over 70 organisations ask
EPHA joins over 70 organisations setting out principles and practices which should be implemented to ensure equitable global access for treatments, vaccines and diagnostics resulting from the ACT Acceleratorread more
EPHA joins calls for clear plans to increase the accountability and public ownership of this COVID-19 pledging initiative and
subsequent activities to ensure equal access for all.
Analysis & Opinion
The coronavirus disease offers pharma companies the possibility for public trust in them to be restored. It remains to be seen if they will grasp this chance.read more
Ellen ‘t Hoen of Medicines Law and Policy on why it is time to change the system of pharmaceutical incentives in the EUread more
Get monthly updates on key public health issues!
Time for a new deal
14 November 2019
4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Putting health first
3 June 2019
Trailblazers, routes to better and affordable medicines by 2025
20 November 2018
How good are our medicines?
3 October 2018
Game changers for better and affordable medicines in Europe
21 November 2017
At the European Health Forum Gastein
Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
+32 2 233 3886